| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S Shigetomi, S Fukuch. Recent aspect of the role of peripheral dopamine and its receptors in the pathogenesis of hypertension. Fukushima journal of medical science. vol 40. issue 2. 1995-09-21. PMID:7642168. |
dopamine is an essential and indispensable catecholamine, which acts not only as a neurotransmitter in dopaminergic and noradrenergic sympathetic neurons but also as an autocrine/paracrine substance in non-neuronal tissues. |
1995-09-21 |
2023-08-12 |
rat |
| D A Cory-Slecht. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Annual review of pharmacology and toxicology. vol 35. 1995-08-01. PMID:7598500. |
relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. |
1995-08-01 |
2023-08-12 |
Not clear |
| F J Seidler, S W Temple, E C McCook, T A Slotki. Cocaine inhibits central noradrenergic and dopaminergic activity during the critical developmental period in which catecholamines influence cell development. Brain research. Developmental brain research. vol 85. issue 1. 1995-07-14. PMID:7781166. |
brain development in the neonatal rat corresponds to fetal stages in man, and thus the transient ability of cocaine to interfere with noradrenergic and dopaminergic activity during the period in which differentiation is being patterned by neurotransmitter input, may be important in the neurobehavioral teratology of cocaine. |
1995-07-14 |
2023-08-12 |
rat |
| C M Miner, J R Davidso. Biological characterization of social phobia. European archives of psychiatry and clinical neuroscience. vol 244. issue 6. 1995-07-07. PMID:7772613. |
based on studies of neurotransmitter functions and pharmacologic response, the major neurotransmitter systems that have been implicated are the serotonergic, dopaminergic, and noradrenergic. |
1995-07-07 |
2023-08-12 |
Not clear |
| N Ogaw. Molecular and chemical neuropharmacology of dopamine receptor subtypes. Acta medica Okayama. vol 49. issue 1. 1995-06-28. PMID:7762403. |
in the fields of psychiatry and neurology, the dopaminergic system is one of the most important neurotransmitter systems in the brain. |
1995-06-28 |
2023-08-12 |
Not clear |
| M Hansenne, W Pitchot, A Gonzalez Moreno, P Papart, M Timsit-Berthier, M Anssea. Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines). Electroencephalography and clinical neurophysiology. vol 96. issue 2. 1995-05-04. PMID:7535224. |
p300 amplitude appears to be modulated by multiple neurotransmitter systems, especially dopaminergic, noradrenergic as well as cholinergic and gabaergic. |
1995-05-04 |
2023-08-12 |
human |
| D J Sirinathsinghji, R Schuligoi, R P Heavens, A Dixon, S D Iversen, R G Hil. Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist. Neuroscience. vol 62. issue 2. 1995-02-17. PMID:7830888. |
the cellular immediate early genes are involved in the transcriptional events associated with the dopaminergic regulation of neurotransmitter expression within neurons of the neostriatum. |
1995-02-17 |
2023-08-12 |
rat |
| J Kornhuber, M Welle. [Current status of biochemical hypotheses in the pathogenesis of schizophrenia]. Der Nervenarzt. vol 65. issue 11. 1995-02-09. PMID:7816150. |
the main focus of interest has shifted in recent years from the classical dopamine hypothesis to an increasing set of various neurotransmitter imbalance models of schizophrenic psychoses involving not only the dopaminergic system but also glutamatergic, serotonergic, cholinergic, gabaergic or peptidergic neuron systems. |
1995-02-09 |
2023-08-12 |
human |
| Iu A Skrinskaia, E M Nikulin. [The effect of deprenil on the dopaminergic system of the brain in mice of different genotypes during aging]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova. vol 44. issue 4-5. 1995-01-27. PMID:7810226. |
effects of aging on brain dopaminergic system, e.g., neurotransmitter metabolism and different kinds of dopamine-dependent behaviour, were studied in mice of three inbred strains. |
1995-01-27 |
2023-08-12 |
mouse |
| K W Lange, P Riederer, M B Youdi. Biochemical actions of l-deprenyl (selegiline). Clinical pharmacology and therapeutics. vol 56. issue 6 Pt 2. 1995-01-18. PMID:7995015. |
because parkinson's disease is characterized by a decrease in dopaminergic neurotransmission in the basal ganglia, the selective inhibition of mao-b should lead to diminished metabolism of dopamine in the nigrostriatal system and a significant increase in the concentration of the neurotransmitter. |
1995-01-18 |
2023-08-12 |
human |
| F Issa, G A Gerhardt, J J Bartko, R L Suddath, M Lynch, P H Gamache, R Freedman, R J Wyatt, D G Kirc. A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: I. Comparisons with healthy control subjects and neuroleptic-treated/unmedicated pairs analyses. Psychiatry research. vol 52. issue 3. 1995-01-09. PMID:7991718. |
this approach enabled the study of the interactions of several metabolites of each of the three major neurotransmitter pathways (dopaminergic, noradrenergic, and serotonergic) to test existing hypotheses regarding the neurobiochemical basis of schizophrenia. |
1995-01-09 |
2023-08-12 |
human |
| D G Cole, J H Growdo. Therapy for progressive supranuclear palsy: past and future. Journal of neural transmission. Supplementum. vol 42. 1994-12-22. PMID:7964693. |
neurotransmitter replacement strategies targeting the dopaminergic, cholinergic, and serotonergic systems have been unsuccessful. |
1994-12-22 |
2023-08-12 |
Not clear |
| N Khan, A Antonini, D Parkes, M J Dahlitz, K Meier-Ewert, A Weindl, K L Leender. Striatal dopamine D2 receptors in patients with narcolepsy measured with PET and 11C-raclopride. Neurology. vol 44. issue 11. 1994-12-20. PMID:7969966. |
there was no evidence of involvement of the striatal d2 dopaminergic neurotransmitter system in the basic pathophysiology of the narcoleptic syndrome despite an age-related increase in putaminal 11c-raclopride uptake. |
1994-12-20 |
2023-08-12 |
human |
| M J Aminof. Treatment of Parkinson's disease. The Western journal of medicine. vol 161. issue 3. 1994-12-15. PMID:7975571. |
other therapeutic strategies are being explored, including the use of type b monoamine oxidase inhibitors to reduce the metabolic breakdown of dopamine, catechol-o-methyltransferase inhibitors to retard the breakdown of levodopa, norepinephrine precursors to compensate for deficiency of this neurotransmitter, glutamate antagonists to counteract the effects of the subthalamic nucleus, and various neurotrophic factors to influence dopaminergic nigrostriatal cells. |
1994-12-15 |
2023-08-12 |
Not clear |
| C Gilber. Neurotransmitter status and remission of rheumatoid arthritis in pregnancy. The Journal of rheumatology. vol 21. issue 6. 1994-10-25. PMID:7932415. |
it is proposed (1) that a reset of neurotransmitter status early in pregnancy (associated with enhanced dopaminergic (da) activity and subtly modified norepinephrinergic-da functional interrelationships, and altered cholinergic function) initiates and maintains specific changes in immunological responses and in the endocrine system; that these changes collectively impose an alternative order of efficient physiological function and metabolism which is inimical to the progress of ra and promotes remission and, as reported, also prevents onset of the disease in normal pregnancy; (2) that pregnancy converges the ans profile of caucasians on the profile normally observed in nonpregnant africans and is accompanied by the emergence of resemblances in certain aspects of metabolism; (3) that the reported low incidence of ra in non-pregnant africans and suppression of onset and remission of the disease in pregnant caucasians underline the proposed major influence of a specific neurotransmitter profile in determining the risk for and course of ra. |
1994-10-25 |
2023-08-12 |
Not clear |
| V Silani, D Mariani, F M Donato, C Ghezzi, F Mazzucchelli, M Buscaglia, G Pardi, G Scarlat. Development of dopaminergic neurons in the human mesencephalon and in vitro effects of basic fibroblast growth factor treatment. Experimental neurology. vol 128. issue 1. 1994-09-23. PMID:7915238. |
glial fibrillary acidic protein (gfap) was first observed at pc week 10.0 instead, after the dopaminergic neurotransmitter phenotype expression. |
1994-09-23 |
2023-08-12 |
human |
| M A Malone, J R Kershner, J M Swanso. Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder. Journal of child neurology. vol 9. issue 2. 1994-07-19. PMID:8006372. |
to advance our understanding of attention-deficit hyperactivity disorder and medication effects we draw upon the evidence for (1) a neurotransmitter imbalance between norepinephrine and dopamine in attention-deficit hyperactivity disorder and (2) an asymmetric neural control system that links the dopaminergic pathways to left hemispheric processing and links the noradrenergic pathways to right hemispheric processing. |
1994-07-19 |
2023-08-12 |
Not clear |
| M E Alburges, J K Wamsle. Effects on monoamine levels in rat CNS after chronic administration of cocaine. Investigacion clinica. vol 34. issue 4. 1994-07-15. PMID:7516188. |
these results suggest that changes in the dopaminergic receptor system following chronic cocaine exposure are not due to changes in the neurotransmitter concentrations. |
1994-07-15 |
2023-08-12 |
rat |
| M J Druse, N F Tajuddin, M Eshed, R Gillespi. Maternal ethanol consumption: effects on G proteins and second messengers in brain regions of offspring. Alcoholism, clinical and experimental research. vol 18. issue 1. 1994-06-30. PMID:8198226. |
previous work in this and other laboratories has demonstrated that in utero ethanol exposure adversely affects the development of the serotonergic, dopaminergic, cholinergic, and other neurotransmitter systems. |
1994-06-30 |
2023-08-12 |
rat |
| A Płaźnik, W Kostowsk. [A new concept of antidepressant drugs action: clinical and preclinical data]. Psychiatria polska. vol 28. issue 1. 1994-06-17. PMID:7910691. |
some clinical data and more equivocally preclinical studies indicate an enhancement of activity of those neurotransmitter systems which exert an activating impact on diverse cns functions (dopaminergic and alpha-1 adrenergic receptors). |
1994-06-17 |
2023-08-12 |
Not clear |